Should Babies Have Their Genomes Sequenced?

De: Anna Nowogrodzki

Narrado por: Todd Mundt

Duración: 5 m

Resumen del Editor

For 51 years, newborn babies have gotten a heel-prick test in which their blood is screened for dozens of congenital disorders. Routine newborn screening has basically eliminated the risk of death or irreversible brain damage that some of these disorders can pose if they are not identified right away. Now some researchers in Boston are trying to find out if genomic sequencing at birth would be as successful. The BabySeq project is the first randomized, controlled trial to measure the harms and benefits of newborn genomic sequencing. One of four NIH-funded projects granted a total of $25 million to examine genomic sequencing in newborns, BabySeq recently enrolled its first four subjects, three healthy babies and one baby from the neonatal ICU.

©Massachusetts Institute of Technology (P)Massachusetts Institute of Technology